Yacaman HIV studies 2007

University of Texas at Austin licenses nanoparticles that could prevent HIV infections

A chemical engineer at The University of Texas at Austin has developed a type of silver nanoparticle that prevents HIV from interacting with human cells. The university has licensed the anti-virus technology developed in the laboratory of Dr. Miguel Jose Yacaman to XXX. The XX-based company will begin investigating the nanoparticles' potential to serve as a new treatment for the human immunodeficiency virus that causes AIDS.



Photo by Erin McCarley, 5/2007  
Click on photo for hi-res version.

Photo at left: Dr. Miguel Jose Yacaman with a focused ion beam machine used to prepare samples of HIV and silver nanoparticles for viewing on the electron microscope.


Photo by Dr. Miguel Jose Yacaman  
Click on photo for hi-res version.

Photo at left: A transmission electron microscope image of HIV virus (four large objects), with silver nanoparticles on their surfaces (bright dots). The microscope visualizes objects about 1 micrometer (one millionth of a meter) in size.


Photo by Erin McCarley, 5/2007
Click on photo for hi-res version.

Photo at left: Dr. Jose Yacaman has been studying the biological potential of nanoparticles for decades. Among his students is Reeja Jayan. The doctoral student in electrical engineering poses with gold nanoparticles displayed on a computer screen.

 

 


Photo by Erin McCarley, 5/2007
Click on photo for hi-res version.

Photo at left: Selene Sepulveda Guzman, post-doctoral fellow in chemical engineering, also assists Dr. Yacaman with nanoparticle research. The colorful bottled materials appearing in the background are vials of ZnO nanoparticles under a UV lamp. These nanoparticles have potential application as biosensors.